AN2 Therapeutics

AN2 Therapeutics

Yahoo Finance • 13 days ago

AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)

MENLO PARK, Calif., October 23, 2026--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announce... Full story

Yahoo Finance • 29 days ago

GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships

GSK (LSE:GSK) has entered a collaboration with Wave Life Sciences to advance a GalNAc-siRNA hepatology candidate into its development pipeline. The partnership with Wave Life Sciences focuses on RNA-based therapies targeting liver diseases... Full story

Yahoo Finance • 12 months ago

AN2 Therapeutics reports Q3 results

* AN2 Therapeutics press release [https://seekingalpha.com/pr/20304970-an2-therapeutics-reports-third-quarter-2025-financial-results-and-recent-business-and] (ANTX [https://seekingalpha.com/symbol/ANTX]): Q3 net loss was $9.4 million.... Full story

Yahoo Finance • last year

AN2 Therapeutics’ SWOT analysis: stock’s potential amid pipeline setbacks

AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases, finds itself at a critical juncture following recent clinical trial results and strategi... Full story